This research report focuses on the Meningococcal Vaccine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Study Coverage
- 1.1 Meningococcal Vaccine Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Meningococcal Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Meningtits A
- 1.2.3 Polysaccharide Meningtitis AC
- 1.2.4 Meningitis ACYW
- 1.3 Market by Application
- 1.3.1 Global Meningococcal Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 6 Months-15Year
- 1.3.3 over 3 Year
- 1.3.4 over 2 Year
- 1.3.5 over 3 Months
- 1.4 Study Objectives
- 1.5 Years Considered
2 Executive Summary
- 2.1 Global Meningococcal Vaccine Sales Estimates and Forecasts 2017-2028
- 2.2 Global Meningococcal Vaccine Revenue Estimates and Forecasts 2017-2028
- 2.3 Global Meningococcal Vaccine Revenue by Region: 2017 VS 2021 VS 2028
- 2.4 Global Meningococcal Vaccine Sales by Region
- 2.4.1 Global Meningococcal Vaccine Sales by Region (2017-2022)
- 2.4.2 Global Sales Meningococcal Vaccine by Region (2023-2028)
- 2.5 Global Meningococcal Vaccine Revenue by Region
- 2.5.1 Global Meningococcal Vaccine Revenue by Region (2017-2022)
- 2.5.2 Global Meningococcal Vaccine Revenue by Region (2023-2028)
- 2.6 North America
- 2.7 Europe
- 2.8 Asia-Pacific
- 2.9 Latin America
- 2.10 Middle East & Africa
3 Competition by Manufacturers
- 3.1 Global Meningococcal Vaccine Sales by Manufacturers
- 3.1.1 Global Top Meningococcal Vaccine Manufacturers by Sales (2017-2022)
- 3.1.2 Global Meningococcal Vaccine Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Meningococcal Vaccine in 2021
- 3.2 Global Meningococcal Vaccine Revenue by Manufacturers
- 3.2.1 Global Meningococcal Vaccine Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Meningococcal Vaccine Revenue in 2021
- 3.3 Global Meningococcal Vaccine Sales Price by Manufacturers (2017-2022)
- 3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Meningococcal Vaccine Manufacturers Geographical Distribution
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Global Meningococcal Vaccine Sales by Type
- 4.1.1 Global Meningococcal Vaccine Historical Sales by Type (2017-2022)
- 4.1.2 Global Meningococcal Vaccine Forecasted Sales by Type (2023-2028)
- 4.1.3 Global Meningococcal Vaccine Sales Market Share by Type (2017-2028)
- 4.2 Global Meningococcal Vaccine Revenue by Type
- 4.2.1 Global Meningococcal Vaccine Historical Revenue by Type (2017-2022)
- 4.2.2 Global Meningococcal Vaccine Forecasted Revenue by Type (2023-2028)
- 4.2.3 Global Meningococcal Vaccine Revenue Market Share by Type (2017-2028)
- 4.3 Global Meningococcal Vaccine Price by Type
- 4.3.1 Global Meningococcal Vaccine Price by Type (2017-2022)
- 4.3.2 Global Meningococcal Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
- 5.1 Global Meningococcal Vaccine Sales by Application
- 5.1.1 Global Meningococcal Vaccine Historical Sales by Application (2017-2022)
- 5.1.2 Global Meningococcal Vaccine Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Meningococcal Vaccine Sales Market Share by Application (2017-2028)
- 5.2 Global Meningococcal Vaccine Revenue by Application
- 5.2.1 Global Meningococcal Vaccine Historical Revenue by Application (2017-2022)
- 5.2.2 Global Meningococcal Vaccine Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Meningococcal Vaccine Revenue Market Share by Application (2017-2028)
- 5.3 Global Meningococcal Vaccine Price by Application
- 5.3.1 Global Meningococcal Vaccine Price by Application (2017-2022)
- 5.3.2 Global Meningococcal Vaccine Price Forecast by Application (2023-2028)
6 North America
- 6.1 North America Meningococcal Vaccine Market Size by Type
- 6.1.1 North America Meningococcal Vaccine Sales by Type (2017-2028)
- 6.1.2 North America Meningococcal Vaccine Revenue by Type (2017-2028)
- 6.2 North America Meningococcal Vaccine Market Size by Application
- 6.2.1 North America Meningococcal Vaccine Sales by Application (2017-2028)
- 6.2.2 North America Meningococcal Vaccine Revenue by Application (2017-2028)
- 6.3 North America Meningococcal Vaccine Market Size by Country
- 6.3.1 North America Meningococcal Vaccine Sales by Country (2017-2028)
- 6.3.2 North America Meningococcal Vaccine Revenue by Country (2017-2028)
- 6.3.3 U.S.
- 6.3.4 Canada
7 Europe
- 7.1 Europe Meningococcal Vaccine Market Size by Type
- 7.1.1 Europe Meningococcal Vaccine Sales by Type (2017-2028)
- 7.1.2 Europe Meningococcal Vaccine Revenue by Type (2017-2028)
- 7.2 Europe Meningococcal Vaccine Market Size by Application
- 7.2.1 Europe Meningococcal Vaccine Sales by Application (2017-2028)
- 7.2.2 Europe Meningococcal Vaccine Revenue by Application (2017-2028)
- 7.3 Europe Meningococcal Vaccine Market Size by Country
- 7.3.1 Europe Meningococcal Vaccine Sales by Country (2017-2028)
- 7.3.2 Europe Meningococcal Vaccine Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia
8 Asia Pacific
- 8.1 Asia Pacific Meningococcal Vaccine Market Size by Type
- 8.1.1 Asia Pacific Meningococcal Vaccine Sales by Type (2017-2028)
- 8.1.2 Asia Pacific Meningococcal Vaccine Revenue by Type (2017-2028)
- 8.2 Asia Pacific Meningococcal Vaccine Market Size by Application
- 8.2.1 Asia Pacific Meningococcal Vaccine Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Meningococcal Vaccine Revenue by Application (2017-2028)
- 8.3 Asia Pacific Meningococcal Vaccine Market Size by Region
- 8.3.1 Asia Pacific Meningococcal Vaccine Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Meningococcal Vaccine Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 China Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
9 Latin America
- 9.1 Latin America Meningococcal Vaccine Market Size by Type
- 9.1.1 Latin America Meningococcal Vaccine Sales by Type (2017-2028)
- 9.1.2 Latin America Meningococcal Vaccine Revenue by Type (2017-2028)
- 9.2 Latin America Meningococcal Vaccine Market Size by Application
- 9.2.1 Latin America Meningococcal Vaccine Sales by Application (2017-2028)
- 9.2.2 Latin America Meningococcal Vaccine Revenue by Application (2017-2028)
- 9.3 Latin America Meningococcal Vaccine Market Size by Country
- 9.3.1 Latin America Meningococcal Vaccine Sales by Country (2017-2028)
- 9.3.2 Latin America Meningococcal Vaccine Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina
10 Middle East and Africa
- 10.1 Middle East and Africa Meningococcal Vaccine Market Size by Type
- 10.1.1 Middle East and Africa Meningococcal Vaccine Sales by Type (2017-2028)
- 10.1.2 Middle East and Africa Meningococcal Vaccine Revenue by Type (2017-2028)
- 10.2 Middle East and Africa Meningococcal Vaccine Market Size by Application
- 10.2.1 Middle East and Africa Meningococcal Vaccine Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Meningococcal Vaccine Revenue by Application (2017-2028)
- 10.3 Middle East and Africa Meningococcal Vaccine Market Size by Country
- 10.3.1 Middle East and Africa Meningococcal Vaccine Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Meningococcal Vaccine Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia
11 Company Profiles
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Overview
- 11.1.3 Novartis Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 Novartis Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 Novartis Recent Developments
- 11.2 GSK
- 11.2.1 GSK Corporation Information
- 11.2.2 GSK Overview
- 11.2.3 GSK Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 GSK Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 GSK Recent Developments
- 11.3 Merck
- 11.3.1 Merck Corporation Information
- 11.3.2 Merck Overview
- 11.3.3 Merck Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.3.4 Merck Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Merck Recent Developments
- 11.4 CSL
- 11.4.1 CSL Corporation Information
- 11.4.2 CSL Overview
- 11.4.3 CSL Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.4.4 CSL Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 CSL Recent Developments
- 11.5 Baxter
- 11.5.1 Baxter Corporation Information
- 11.5.2 Baxter Overview
- 11.5.3 Baxter Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.5.4 Baxter Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Baxter Recent Developments
- 11.6 JN International Medical Corporation
- 11.6.1 JN International Medical Corporation Corporation Information
- 11.6.2 JN International Medical Corporation Overview
- 11.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.6.4 JN International Medical Corporation Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 JN International Medical Corporation Recent Developments
- 11.7 Serum Institute of India
- 11.7.1 Serum Institute of India Corporation Information
- 11.7.2 Serum Institute of India Overview
- 11.7.3 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.7.4 Serum Institute of India Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Serum Institute of India Recent Developments
- 11.8 Bio-Med
- 11.8.1 Bio-Med Corporation Information
- 11.8.2 Bio-Med Overview
- 11.8.3 Bio-Med Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.8.4 Bio-Med Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 Bio-Med Recent Developments
- 11.9 China National Biotec Group
- 11.9.1 China National Biotec Group Corporation Information
- 11.9.2 China National Biotec Group Overview
- 11.9.3 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.9.4 China National Biotec Group Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 China National Biotec Group Recent Developments
- 11.10 Hualan Bio
- 11.10.1 Hualan Bio Corporation Information
- 11.10.2 Hualan Bio Overview
- 11.10.3 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.10.4 Hualan Bio Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.10.5 Hualan Bio Recent Developments
- 11.11 Walvax
- 11.11.1 Walvax Corporation Information
- 11.11.2 Walvax Overview
- 11.11.3 Walvax Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.11.4 Walvax Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.11.5 Walvax Recent Developments
- 11.12 Zhifei
- 11.12.1 Zhifei Corporation Information
- 11.12.2 Zhifei Overview
- 11.12.3 Zhifei Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.12.4 Zhifei Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
- 11.12.5 Zhifei Recent Developments
12 Industry Chain and Sales Channels Analysis
- 12.1 Meningococcal Vaccine Industry Chain Analysis
- 12.2 Meningococcal Vaccine Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
- 12.3 Meningococcal Vaccine Production Mode & Process
- 12.4 Meningococcal Vaccine Sales and Marketing
- 12.4.1 Meningococcal Vaccine Sales Channels
- 12.4.2 Meningococcal Vaccine Distributors
- 12.5 Meningococcal Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
- 13.1 Meningococcal Vaccine Industry Trends
- 13.2 Meningococcal Vaccine Market Drivers
- 13.3 Meningococcal Vaccine Market Challenges
- 13.4 Meningococcal Vaccine Market Restraints
14 Key Findings in The Global Meningococcal Vaccine Study
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Author Details
- 15.3 Disclaimer